BIOFILCHEM · Healthcare · Drug Manufacturers - Specialty & Generic
Composite scorecard: 40/100 — Quality 41 · Valuation 64 · Momentum 0
| Share price | ₹33.17 |
| Market cap | ₹55 Cr |
| P/E ratio | 19.9 |
| P/B ratio | 2.6 |
| ROE | 17.1% |
| ROCE | 15.6% |
| Book value | ₹13.21 |
| Year | Sales | Net profit | OPM |
|---|---|---|---|
| 2026 | ₹28 Cr | ₹3 Cr | 1.3% |
| 2025 | ₹33 Cr | ₹1 Cr | 1.4% |
| 2024 | ₹40 Cr | ₹1 Cr | 1.0% |
| 2023 | ₹30 Cr | ₹1 Cr | 2.5% |
| 2022 | — | — | — |
Biofil Chemicals and Pharmaceuticals Limited engages in manufacturing and trading of pharmaceuticals in India. It operates through Pharmaceutical and Chemical divisions. The company offers basic drugs and chemicals, such as sodium chloride, potassium chloride, sodium citrate, diethyl carbamazine citrate, ferrous sulphate, dried ferrous sulphate, ferrous fumerate, micro crystalline cellulose, and dicyclomine hydrochloride; and packaging solutions. It also provides job work service for manufacturing pharmaceutical drugs. Biofil Chemicals and Pharmaceuticals Limited was incorporated in 1985 and i